BATS | ETF
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements.
The fund invests predominantly in common stock.
Although it may invest across economic sectors, the fund concentrates its investments in health care related industries.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 5.70% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 4.73% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 4.68% |
| MEDP | Medpace Holdings Inc | Healthcare | Diagnostics & Research | 4.67% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 4.57% |
| KRYS | Krystal Biotech Inc | Healthcare | Biotechnology | 3.84% |
| TEM | Tempus AI, Inc. Class A Common Stock | Healthcare | Health Information Services | 3.74% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 3.64% |
| 207940 | Samsung Biologics Co Ltd | Healthcare | Biotechnology | 3.43% |
| LGND | Ligand Pharmaceuticals Incorporated | Healthcare | Biotechnology | 3.30% |
| ADPT | Adaptive Biotechnologies Corp | Healthcare | Biotechnology | 3.28% |
| BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 3.07% |
| AZN | AstraZeneca PLC ADR | Healthcare | Drug Manufacturers - General | 2.92% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 2.79% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 2.53% |
| CTVA | Corteva Inc | Basic Materials | Agricultural Inputs | 2.50% |
| BNTX | BioNTech SE | Healthcare | Biotechnology | 2.18% |
| WGS | GeneDx Holdings Corp. | Healthcare | Diagnostics & Research | 2.06% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.00% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 1.70% |